素的下调会诱导中性友性喘中的炎症酶激活
Quang Luu Quoc1, YeJi Kim2, Gunwoo Park1
1Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Korea; Department of Biomedical Sciences, Ajou University School of Medicine, Suwon, Korea.
The Journal of allergy and clinical immunology
|April 10, 2024
概括
卵巢瘤蛋白酶二基因酶与线性链接特异性 (otulin) 缺乏在巨细胞驱动中性友性喘通过激活NLRP3炎症和IL-1β生产. 向otulin提供了严重喘的潜在治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 中性性喘 (NA) 是一种严重的表型,与类固醇耐药性和互乐素-1β (IL-1β) 过量产生有关.
- 驱动NA的确切机制尚不清楚,但TNF-α通路功能障碍和卵巢瘤蛋白酶二维基因酶与线性链接特异性 (otulin) 缺陷与自身免疫性疾病有关.
研究的目的:
- 为了研究一种假设,即巨细胞 (Mφ) 中的素降低调节会激活核酸结合域,富含白素的重复和含蛋白域的蛋白3 (NLRP3) 炎症体信号通路.
- 探索奥图林在NA病变发生中的作用.
主要方法:
- 从NA患者的血液单细胞子集和从NA小鼠的膜Mφ中评估了otulin表达.
- 在骨髓衍生的Mφ中评估了素缺乏的功能后果.φ.
- 研究受体相互作用蛋白激酶 (RIPK) -1和RIPK-3抑制对中性粒细胞和3组先天性淋巴细胞 (ILC3) 的 in vitro 和 in vivo 影响.
主要成果:
- 与健康对照人群相比,在NA患者的非经典单细胞中观察到显著的奥图林下调.
- 来自NA小鼠的膜Mφ显示了素表达的减少.
- 在Mφ中,奥图林的淘汰导致通过NLRP3炎症酶激活自发IL-1β的产生.
- 结合RIPK-1和RIPK-3的抑制通过阻断NA中的IL-1β释放减少了中性粒细胞和ILC3的透.
结论:
- 在上游因素奥图林的缺乏会引发IL-1β的过度产生,这表明它是NA的潜在诊断和治疗点.
- 向otulin-NLRP3炎症酶轴可能为严重的中性友性喘提供一种新的治疗策略.
相关概念视频
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma: Pathogenesis and Management
391
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
391
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
284
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
284
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Inflammation
53.4K
Overview
53.4K


